Modulating effects of the extracellular sequence of the human insulinlike growth factor I receptor on its transforming and tumorigenic potential

We reported previously that an N-terminally truncated insulinlike growth factor I receptor (IGFR) fused to avian sarcoma virus UR2 gag p19 had a greater transforming potential than did the native IGFR, but it failed to cause tumors in vivo. To investigate whether the 36 amino acids (aa) of the IGFR extracellular (EC) sequence in the gag-IGFR fusion protein encoded by the retrovirus UIGFR have a modulatory effect on the biological and biochemical properties of the protein, four mutants, NM1, NM2, NM3, and NM4 of the EC sequence were constructed. NM1 lacks the entire 36 aa residues; NM2 lacks the N-terminal 16 aa residues (aa 870 to 885), including two potential N-linked glycosylation sites of the EC sequence; NM3 contains a deletion of the C-terminal 20 aa residues (aa 886 to 905) of the EC sequence; and NM4 contains N-to-Q substitutions at both N-linked glycosylation sites. NM1 was the strongest of the four mutants in promoting anchorage-independent growth of transfected chicken embryo fibroblasts, while NM2 and NM4 had weaker transforming potential than did the original UIGFR virus. Only NM1 and NM3 were able to induce sarcomas in chickens. The four NM mutant-transformed cells expressed the expected proteins with comparable steady-state levels. The in vitro tyrosine kinase activity of P53NM1 was about fourfold higher than that of the parental P57-75UIGFR, whereas NM2 and NM4 proteins exhibited four- to fivefold-lower kinase activities. Despite lacking the IGFR EC sequence, P53NM1 formed covalent dimers similar to those formed by the parental P57-75UIGFR. Increased phosphatidylinositol (PI) 3-kinase activity was found to be associated with the mutant IGFR proteins. Among NM4 proteins. Elevated tyrosine phosphorylation of cellular proteins of 35, 120, 140, 160, and 170 kDa was detected in all mutant IGFR-transformed cells. We conclude that the EC 36-aa sequence of IGFR in the gag-IGFR fusion protein exerts intricate modulatory effects on the protein's transforming and tumorigenic potential. The 20 aa residues immediately upstream of the transmembrane domain have an inhibitory effect on the tumorigenic potential of gag-IGFR, whereas N-linked glycosylation within the EC sequence appears to have a positive effect on the transforming potential of UIGFR. Increased in vitro kinase activity and, to a lesser extent, in vivo tyrosine phosphorylation as well as the elevated association of PI 3-kinase activity with IGFR proteins seem to be correlated with the transforming potential of IGFR mutant proteins.

[1]  M. White,et al.  YMXM motifs of IRS-1 define substrate specificity of the insulin receptor kinase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[2]  A. Ullrich,et al.  Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors , 1992, Molecular and cellular biology.

[3]  L. Cantley,et al.  Transformation-defective mutants of polyomavirus middle T antigen associate with phosphatidylinositol 3-kinase (PI 3-kinase) but are unable to maintain wild-type levels of PI 3-kinase products in intact cells , 1992, Journal of virology.

[4]  D. Baltimore,et al.  Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo , 1992, Molecular and cellular biology.

[5]  W. Rutter,et al.  Enhancement of transforming potential of human insulinlike growth factor 1 receptor by N-terminal truncation and fusion to avian sarcoma virus UR2 gag sequence , 1992, Journal of virology.

[6]  C. Kahn,et al.  Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein , 1991, Nature.

[7]  J. Schlessinger,et al.  Platelet-derived growth factor (PDGF)-induced disulfide-linked dimerization of PDGF receptor in living cells , 1991, Molecular and cellular biology.

[8]  T Pawson,et al.  SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. , 1991, Science.

[9]  V. Fried,et al.  cDNA cloning of a Novel 85 kd protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF β-receptor , 1991, Cell.

[10]  M. Barbacid,et al.  The trk proto-oncogene encodes a receptor for nerve growth factor , 1991, Cell.

[11]  G. Panayotou,et al.  Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase , 1991, Cell.

[12]  H. Hanafusa,et al.  Requirement of phosphatidylinositol-3 kinase modification for its association with p60src , 1991, Molecular and cellular biology.

[13]  A. Costantino,et al.  Overexpression of insulin receptors in fibroblast and ovary cells induces a ligand-mediated transformed phenotype. , 1991, Molecular endocrinology.

[14]  H. Hanafusa,et al.  Deletions in the SH2 domain of p60v-src prevent association with the detergent-insoluble cellular matrix , 1991, Molecular and cellular biology.

[15]  J. Rubin,et al.  Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. , 1991, Science.

[16]  W. Rutter,et al.  Molecular basis of the activation of the tumorigenic potential of Gag-insulin receptor chimeras. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[17]  L. Wang,et al.  The proto-oncogene c-ros codes for a transmembrane tyrosine protein kinase sharing sequence and structural homology with sevenless protein of Drosophila melanogaster. , 1991, Oncogene.

[18]  C. Turck,et al.  A phosphatidylinositol-3 kinase binds to platelet-derived growth factor receptors through a specific receptor sequence containing phosphotyrosine , 1991, Molecular and cellular biology.

[19]  T. Hunter.  Cooperation between oncogenes , 1991, Cell.

[20]  L. Cantley,et al.  Oncogenes and signal transduction , 1991, Cell.

[21]  M. Moran,et al.  Binding of SH2 domains of phospholipase C gamma 1, GAP, and Src to activated growth factor receptors. , 1990, Science.

[22]  L. Cantley,et al.  Purification and characterization of phosphoinositide 3-kinase from rat liver. , 1990, The Journal of biological chemistry.

[23]  T Pawson,et al.  Src homology region 2 domains direct protein-protein interactions in signal transduction. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Ullrich,et al.  Transphosphorylation as a possible mechanism for insulin and epidermal growth factor receptor activation. , 1990, The Journal of biological chemistry.

[25]  P. Leder,et al.  The hematopoietic growth factor KL is encoded by the SI locus and is the ligand of the c-kit receptor, the gene product of the W locus , 1990, Cell.

[26]  Jonathan A. Cooper,et al.  Phosphorylation of the PDGF receptor beta subunit creates a tight binding site for phosphatidylinositol 3 kinase. , 1990, The EMBO journal.

[27]  S. Courtneidge,et al.  Association between the PDGF receptor and members of the src family of tyrosine kinases , 1990, Cell.

[28]  B. Mayer,et al.  Mutagenic analysis of the v-crk oncogene: requirement for SH2 and SH3 domains and correlation between increased cellular phosphotyrosine and transformation , 1990, Journal of virology.

[29]  A. Ullrich,et al.  Evidence for epidermal growth factor (EGF)-induced intermolecular autophosphorylation of the EGF receptors in living cells , 1990, Molecular and cellular biology.

[30]  M. Weber,et al.  Constitutive phosphorylation of the receptor for insulinlike growth factor I in cells transformed by the src oncogene , 1990, Molecular and cellular biology.

[31]  H. Kung,et al.  Activated type I phosphatidylinositol kinase is associated with the epidermal growth factor (EGF) receptor following EGF stimulation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[33]  D. Morrison,et al.  PDGF β-receptor stimulates tyrosine phosphorylation of GAP and association of GAP with a signaling complex , 1990, Cell.

[34]  Jonathan A. Cooper,et al.  Binding of GAP to activated PDGF receptors. , 1990, Science.

[35]  L. Cantley,et al.  Activation of phosphatidylinositol 3-kinase by insulin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Moran,et al.  Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases , 1990, Nature.

[37]  R. Roth,et al.  Phosphatidylinositol kinase or an associated protein is a substrate for the insulin receptor tyrosine kinase. , 1990, The Journal of biological chemistry.

[38]  L. Cantley,et al.  The colony stimulating factor-1 receptor associates with and activates phosphatidylinositol-3 kinase , 1989, Nature.

[39]  A. Ullrich,et al.  Intermolecular transphosphorylation between insulin receptors and EGF‐insulin receptor chimerae. , 1989, The EMBO journal.

[40]  M. Czech.  Signal transmission by the insulin-like growth factors , 1989, Cell.

[41]  Simeon I. Taylor,et al.  pp-120: A common endogenous substrate for insulin and IGF-1 receptor-associated tyrosine kinase activity in the highly malignant AS-30D rat hepatoma cells , 1989 .

[42]  P. Libby,et al.  PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells , 1989, Cell.

[43]  H. Hanafusa,et al.  Phosphatidylinositol kinase activity associates with viral p60src protein , 1989, Molecular and cellular biology.

[44]  S. Coughlin,et al.  Role of phosphatidylinositol kinase in PDGF receptor signal transduction. , 1989, Science.

[45]  G. Carpenter,et al.  Epidermal growth factor stimulates tyrosine phosphorylation of phospholipase C-II independently of receptor internalization and extracellular calcium. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[46]  G. A. Martin,et al.  Molecular cloning of two types of GAP complementary DNA from human placenta. , 1988, Science.

[47]  Irving S. Sigal,et al.  Cloning of bovine GAP and its interaction with oncogenic ras p21 , 1988, Nature.

[48]  A. Ullrich,et al.  Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity , 1988, Cell.

[49]  S. Ryu,et al.  Inositol phospholipid-specific phospholipase C: complete cDNA and protein sequences and sequence homology to tyrosine kinase-related oncogene products. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[50]  D. Lowy,et al.  Guanosine triphosphatase activating protein (GAP) interacts with the p21 ras effector binding domain. , 1988, Science.

[51]  J. Schlessinger,et al.  Demonstration of epidermal growth factor-induced receptor dimerization in living cells using a chemical covalent cross-linking agent. , 1988, The Journal of biological chemistry.

[52]  W. Rutter,et al.  Activation of transforming potential of the human insulin receptor gene. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[53]  M. Kasuga,et al.  Tyrosine phosphorylation of common and specific sets of cellular proteins rapidly induced by insulin, insulin-like growth factor I, and epidermal growth factor in an intact cell. , 1987, The Journal of biological chemistry.

[54]  Y. Yarden,et al.  Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. , 1987, Biochemistry.

[55]  Simeon I. Taylor,et al.  Rat liver membranes contain a 120 kDa glycoprotein which serves as a substrate for the tyrosine kinases of the receptors for insulin and epidermal growth factor , 1987, FEBS letters.

[56]  A. Ullrich,et al.  Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin. , 1987, The Journal of biological chemistry.

[57]  C Collins,et al.  Insulin‐like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. , 1986, The EMBO journal.

[58]  D. Accili,et al.  Tissue distribution and subcellular localization of an endogenous substrate (pp 120) for the insulin receptor-associated tyrosine kinase. , 1986, Endocrinology.

[59]  M. Shibuya,et al.  Human c-ros-1 gene homologous to the v-ros sequence of UR2 sarcoma virus encodes for a transmembrane receptorlike molecule , 1986, Molecular and cellular biology.

[60]  W. Rutter,et al.  Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose , 1986, Cell.

[61]  M. Shibuya,et al.  Proto-oncogene c-ros codes for a molecule with structural features common to those of growth factor receptors and displays tissue specific and developmentally regulated expression , 1986, Molecular and cellular biology.

[62]  A. Ullrich,et al.  Activation of c‐erbB in avian leukosis virus‐induced erythroblastosis leads to the expression of a truncated EGF receptor kinase. , 1985, The EMBO journal.

[63]  R. Erikson,et al.  Phosphatidylinositol kinase activities in normal and Rous sarcoma virus-transformed cells , 1985, Molecular and cellular biology.

[64]  L. Cantley,et al.  Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation , 1985, Nature.

[65]  L. Wang,et al.  Nucleotide sequence of avian sarcoma virus UR2 and comparison of its transforming gene with other members of the tyrosine protein kinase oncogene family , 1985, Journal of Virology.

[66]  L. Wang,et al.  Molecular cloning and characterization of avian sarcoma virus UR2 and comparison of its transforming sequence with those of other avian sarcoma viruses , 1984, Journal of virology.

[67]  M. Nishizawa,et al.  New procedure for DNA transfection with polycation and dimethyl sulfoxide , 1984, Molecular and cellular biology.

[68]  G. Marinetti,et al.  Transforming protein of avian sarcoma virus UR2 is associated with phosphatidylinositol kinase activity: possible role in tumorigenesis. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[69]  A. Ullrich,et al.  Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences , 1984, Nature.

[70]  M. Czech.  Structural and functional homologies in the receptors for insulin and the insulin-like growth factors , 1982, Cell.

[71]  M. Shibuya,et al.  Some biological properties of two new avian sarcoma viruses , 1981, Journal of virology.

[72]  H. Hanafusa,et al.  Recovery of avian sarcoma virus from tumors induced by transformation- defective mutants , 1977, The Journal of experimental medicine.

[73]  H. Hanafusa.  Rapid transformation of cells by Rous sarcoma virus. , 1969, Proceedings of the National Academy of Sciences of the United States of America.

[74]  J. Schlessinger,et al.  Tyrosine Kinase Activity IsEssential fortheAssociation of Phospholipase C-ywiththeEpidermal GrowthFactor Receptor , 1990 .

[75]  H. Hanafusa,et al.  Phosphatidylinositol kinase type I activity associates with various oncogene products. , 1989, Oncogene research.

[76]  H. Hanafusa,et al.  Genetic Structure and Transforming Sequence of Avian Sarcoma Virus UR 2 , 2022 .